Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Stebbing

Showing results (301-310 of 504) with videos related to

Pageof 51
Sort By:
BMC Medical Genomics|April 16, 2024
An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinomaZhonghai Du, Xiuchen Han, Liping Zhu, et al.
Oncotarget|April 7, 2016
ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradationJoao Nunes, Hua Zhang, Nicos Angelopoulos, et al.
The Journal of Antimicrobial Chemotherapy|May 25, 2005
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterolVictoria Latham, Justin Stebbing, Sundhiya Mandalia, et al.
Annals of Surgery|March 21, 2014
miR-15b and miR-17 Are Tumor-derived Plasma MicroRNAs Dysregulated in Colorectal NeoplasiaAdam E Frampton, Jonathan Krell, Tamara M H Gall, et al.
Expert Review of Molecular Diagnostics|October 17, 2013
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Oncology Research and Treatment|February 3, 2022
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-AnalysisLing Peng, Bao-Dong Qin, Song Xu, et al.
Cancer Gene Therapy|April 4, 2022
Alternative splicing events in tumor immune infiltration in renal clear cell carcinomasZhiqiang Wang, Liping Zhu, Kesang Li, et al.
Blood|April 23, 2011
Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman diseaseJustin Stebbing, Caroline Adams, Adam Sanitt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?Mark Bower, Tom Powles, Tom Newsom-Davis, et al.
British Journal of Haematology|March 29, 2008
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasmsEleftheria Hatzimichael, Aggeliki Dasoula, Leonidas Benetatos, et al.
Pageof 51

Showing results (301-310 of 504) with videos related to

Sort By:
Pageof 51
BMC Medical Genomics|April 16, 2024
An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinomaZhonghai Du, Xiuchen Han, Liping Zhu, et al.
Oncotarget|April 7, 2016
ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradationJoao Nunes, Hua Zhang, Nicos Angelopoulos, et al.
The Journal of Antimicrobial Chemotherapy|May 25, 2005
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterolVictoria Latham, Justin Stebbing, Sundhiya Mandalia, et al.
Annals of Surgery|March 21, 2014
miR-15b and miR-17 Are Tumor-derived Plasma MicroRNAs Dysregulated in Colorectal NeoplasiaAdam E Frampton, Jonathan Krell, Tamara M H Gall, et al.
Expert Review of Molecular Diagnostics|October 17, 2013
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Oncology Research and Treatment|February 3, 2022
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-AnalysisLing Peng, Bao-Dong Qin, Song Xu, et al.
Cancer Gene Therapy|April 4, 2022
Alternative splicing events in tumor immune infiltration in renal clear cell carcinomasZhiqiang Wang, Liping Zhu, Kesang Li, et al.
Blood|April 23, 2011
Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman diseaseJustin Stebbing, Caroline Adams, Adam Sanitt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?Mark Bower, Tom Powles, Tom Newsom-Davis, et al.
British Journal of Haematology|March 29, 2008
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasmsEleftheria Hatzimichael, Aggeliki Dasoula, Leonidas Benetatos, et al.
Pageof 51